Guru Ownership Trend
Guru Analysis for Taysha Gene Therapies, Inc. (TSHA)
Taysha Gene Therapies, Inc. (TSHA), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $11 M.
Top institutional holders include Jefferies Group and Steven Cohen.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $9.97 M net outflow during the quarter.
Recent activity highlights Jefferies Group who dramatically increased their stake. Conversely, Steven Cohen reduced exposure by 88.1%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Taysha Gene Therapies, Inc. (TSHA)
Major holders include Jefferies Group ($2.14 M), Steven Cohen ($2.06 M), Renaissance Technologies (RenTech) ($1.85 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 2 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $9.97 M, with 5 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited TSHA. The total reported sell value was $15.23 M.
Yes, 2 managers opened new positions in TSHA, and 3 increased their existing holdings. The total reported buy value was $5.26 M.